Tg launches 1 Bio, single-use biopharma scale-up hub

The IT Minister announced over `200 crore in new infrastructure upgrades by TGIIC

Hyderabad: In a major boost to India’s biologics and next-generation therapeutics ecosystem, Telangana, on Monday inaugurated 1 Bio, the nation’s first single-use bioprocess design and scale-up facility, marking a pivotal expansion of the Genome Valley innovation cluster. The facility was unveiled by Telangana’s Minister for IT, Electronics & Communications, and Industries & Commerce D Sridhar Babu, who described the launch as the “next wave of growth and leadership” for India’s biopharma sector.

Speaking at the event, Minister Sridhar Babu said, “As Genome Valley marks 25 years, we are setting the course for its next 25 years. 1 Bio is one of India’s most important steps toward democratising access to biologics scale-up and accelerating the journey from discovery to clinical readiness. With this facility, innovations can now advance to pilot and clinical stages in Hyderabad faster, more predictably, and at lower cost.”

To prepare Genome Valley for its next phase of expansion, the Minister announced over Rs200 crore in new infrastructure upgrades by TGIIC, including road widening, new greenfield roads, power augmentation, and landscaping and streetscaping improvements to enhance connectivity and ensure robust utility services within the cluster.

Special Chief Secretary (Industries & ITE&C) Sanjay Kumar highlighted Telangana’s dominant role in national and global life sciences output, noting that the State contributes 40 per cent of India’s pharma production and one-third of global vaccine supply. He said 1 Bio strengthens this leadership by giving innovators access to world-class bioprocess development capacity.

Related Posts

Cancer cure must not be hostage to Big Pharma

In recent years, immunotherapy has expanded the limits of cancer treatment. Therapies that harness the body’s immune system to fight malignant cells have improved survival rates in cancers once considered…

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Pune:- A woman, 34, dia­gnosed with poly­cystic ovary syn­drome, or PCOS, as a teen­ager, saw her first nat­ural men­strual cycle in Feb­ru­ary—six months after start­ing Moun­jaro for weight man­age­ment. This…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients